Federal Rescheduling of Medical Marijuana Rewrites the Tax and Compliance Math for Licensed Operators
Acting Attorney General Todd Blanche signed an order Thursday moving state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act - a regulatory shift that
DEA Rescheduling Push Sends Canopy Growth Stock Higher, Reshaping Sector Expectations
A wave of renewed investor interest hit Canopy Growth Corporation around June 15, 2026, tied directly to fresh movement on federal cannabis rescheduling by the Drug Enforcement Administration. The
ATACH Assembles Legal Team to Defend Federal Cannabis Rescheduling Against Prohibitionist Challenges
The American Trade Association for Cannabis and Hemp has moved quickly to put legal muscle behind the federal government's decision to reclassify cannabis from Schedule I to Schedule III under the
Cresco Labs Registers Medical Cannabis Sites With DEA After Schedule III Shift
For the first time in the company's history, Cresco Labs' dispensary, cultivation, and processing operations are federally recognized - a direct result of the U.S. government's rescheduling of
Medical Marijuana Rescheduling Clears a Path, But Operators Shouldn't Count Their Tax Savings Yet
Acting Attorney General Todd Blanche signed an order this week moving state-licensed medical marijuana from Schedule I to Schedule III under federal law - the most concrete federal policy shift on
Trump's Cannabis Rescheduling Order Gives Stalled Banking Bill New Oxygen
The bipartisan marijuana banking bill has been going nowhere for months - no floor votes scheduled, no active negotiations, barely a conversation. But President Donald Trump's executive order
Denver Welcomes Federal Marijuana Rescheduling as Its Cannabis Industry Contracts
The U.S. Department of Justice announced it would immediately loosen restrictions on certain marijuana products and accelerate reclassification of the drug to a less dangerous category. Denver's top